Issam Chebouti

EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy

Issam Chebouti, Sabine Kasimir‐Bauer, Paul Buderath et al. · Oncotarget · 2017 · 90 citations · Full text

Medicine, Gynecology, Oncology +17

<i>RASSF1A</i>promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA

Lydia Giannopoulou, Issam Chebouti, Kitty Pavlakis et al. · Oncotarget · 2017 · 68 citations · Full text

Medicine, Genetics, Oncology +17

Extracellular vesicle-associated miRNAs in ovarian cancer – design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistance

Jan Dominik Kuhlmann, Issam Chebouti, Rainer Kimmig et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2018 · 56 citations

Medicine, Molecular Medicine, Oncology +17

ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer

Issam Chebouti, Jan Dominik Kuhlmann, Paul Buderath et al. · Oncotarget · 2016 · 51 citations · Full text

Medicine, Cancer Biology, Oncology +17

Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance

Pauline Wimberger, Issam Chebouti, Sabine Kasimir‐Bauer et al. · Gynecologic Oncology · 2014 · 27 citations

Medicine, Gynecology, Oncology +16